Chemoinformaics analysis of 2-HYDROXY-7-METHOXY-2H-1,4-BENZOXAZIN-3(4H)-ONE
| Molecular Weight | 195.174 | nRot | 1 |
| Heavy Atom Molecular Weight | 186.102 | nRig | 12 |
| Exact Molecular Weight | 195.053 | nRing | 2 |
| Solubility: LogS | -2.111 | nHRing | 1 |
| Solubility: LogP | 0.999 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 23 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 1 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 9 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 9 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 6 |
| nHA | 4 | APOL | 25.3391 |
| nHD | 2 | BPOL | 13.9389 |
| QED | 0.499 |
| Synth | 3.084 |
| Natural Product Likeliness | 0.783 |
| NR-PPAR-gamma | 0.012 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.253 |
| HIA | 0.011 |
| CACO-2 | -4.653 |
| MDCK | 0.000014 |
| BBB | 0.799 |
| PPB | 0.627842 |
| VDSS | 0.679 |
| FU | 0.4229 |
| CYP1A2-inh | 0.473 |
| CYP1A2-sub | 0.32 |
| CYP2c19-inh | 0.116 |
| CYP2c19-sub | 0.368 |
| CYP2c9-inh | 0.058 |
| CYP2c9-sub | 0.479 |
| CYP2d6-inh | 0.011 |
| CYP2d6-sub | 0.829 |
| CYP3a4-inh | 0.064 |
| CYP3a4-sub | 0.132 |
| CL | 7.031 |
| T12 | 0.74 |
| hERG | 0.01 |
| Ames | 0.519 |
| ROA | 0.334 |
| SkinSen | 0.749 |
| Carcinogencity | 0.02 |
| EI | 0.614 |
| Respiratory | 0.539 |
| NR-Aromatase | 0.026 |
| Antiviral | No |
| Prediction | 0.8836 |